Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M. Gillham C, et al. Among authors: zophel k. Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29. Radiother Oncol. 2008. PMID: 18514339
Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off.
Luboldt W, Volker T, Wiedemann B, Zöphel K, Wehrmann U, Koch A, Toussaint T, Abolmaali N, Middendorp M, Aust D, Kotzerke J, Grünwald F, Vogl TJ, Luboldt HJ. Luboldt W, et al. Among authors: zophel k. Eur Radiol. 2010 Sep;20(9):2274-85. doi: 10.1007/s00330-010-1772-0. Epub 2010 May 26. Eur Radiol. 2010. PMID: 20503051 Free PMC article.
Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best?
Abolmaali N, Haase R, Koch A, Zips D, Steinbach J, Baumann M, Kotzerke J, Zöphel K. Abolmaali N, et al. Among authors: zophel k. Nuklearmedizin. 2011;50(1):22-7. doi: 10.3413/nukmed-00328-10-07. Epub 2010 Dec 17. Nuklearmedizin. 2011. PMID: 21165537
Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer.
Hentschel M, Appold S, Schreiber A, Abolmaali N, Abramyuk A, Dörr W, Kotzerke J, Baumann M, Zöphel K. Hentschel M, et al. Among authors: zophel k. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1203-11. doi: 10.1007/s00259-011-1759-3. Epub 2011 Feb 25. Eur J Nucl Med Mol Imaging. 2011. PMID: 21350962 Clinical Trial.
123 results